The effect of morning versus evening administration of empagliflozin on its pharmacokinetics and pharmacodynamics characteristics in healthy adults: a two-way crossover, non-randomised trial.

ElDash, Rana M; Raslan, Mohamed A; Shaheen, Sara M; Sabri, Nagwa Ali

ElDash, Rana M; Raslan, Mohamed A; Shaheen, Sara M; Sabri, Nagwa Ali.

Afiliação

ElDash RM; Pharmacy Practice Department, Faculty of Pharmacy, Heliopolis University, Cairo, 11785, Egypt.
Raslan MA; Quality Control, Drug Research Center, Cairo, Egypt.
Shaheen SM; Clinical Pharmacy Department, Faculty of Pharmacy, AinShms University, Cairo, 11566, Egypt.
Sabri NA; Clinical Pharmacy Department, Faculty of Pharmacy, AinShms University, Cairo, 11566, Egypt.

F1000Res ; 10: 321, 2021.

Article em En | MEDLINE | ID: mdl-34123370

Assuntos

Espectrometria de Massas em Tandem; Adulto; Área Sob a Curva; Compostos Benzidrílicos; Estudos Cross-Over; Egito; Glucosídeos; Humanos

Palavras-chave

Bioequivalence; Chronopharmacology; Circadian rhythm.; Diabetes Mellitus; Empagliflozin 10 mg; Pharmacodynamic; Pharmacokinetics; evening dose; morning dose

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Espectrometria de Massas em Tandem Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Humans País/Região como assunto: Africa Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google